98 related articles for article (PubMed ID: 23831361)
21. In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems.
Dorn I; Lazar-Karsten P; Boie S; Ribbat J; Hartwig D; Driller B; Kirchner H; Schlenke P
Transfusion; 2008 Jun; 48(6):1122-32. PubMed ID: 18298595
[TBL] [Abstract][Full Text] [Related]
22. Dynamic cell-cell interactions between cord blood haematopoietic progenitors and the cellular niche are essential for the expansion of CD34+, CD34+CD38- and early lymphoid CD7+ cells.
da Silva CL; Gonçalves R; dos Santos F; Andrade PZ; Almeida-Porada G; Cabral JM
J Tissue Eng Regen Med; 2010 Feb; 4(2):149-58. PubMed ID: 19937912
[TBL] [Abstract][Full Text] [Related]
23. Immobilisation of Delta-like 1 ligand for the scalable and controlled manufacture of hematopoietic progenitor cells in a stirred bioreactor.
Moore RLL; Worrallo MJ; Mitchell PD; Harriman J; Glen KE; Thomas RJ
BMC Biotechnol; 2017 Aug; 17(1):65. PubMed ID: 28778182
[TBL] [Abstract][Full Text] [Related]
24. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
[TBL] [Abstract][Full Text] [Related]
25. Extensive proliferative capacity of single isolated CD34 human cord blood cells in suspension culture.
Xiao M; Broxmeyer HE; Horie M; Grigsby S; Lu L
Blood Cells; 1994; 20(2-3):455-66; discussion 466-7. PubMed ID: 7538351
[TBL] [Abstract][Full Text] [Related]
26. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
[TBL] [Abstract][Full Text] [Related]
27. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
[TBL] [Abstract][Full Text] [Related]
28. Distinct effects of the soluble versus membrane-bound forms of the notch ligand delta-4 on human CD34+CD38low cell expansion and differentiation.
Lahmar M; Catelain C; Poirault S; Dorsch M; Villeval JL; Vainchenker W; Albagli O; Lauret E
Stem Cells; 2008 Mar; 26(3):621-9. PubMed ID: 18055448
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Delta1 promotes differentiation of odontoblasts and inhibits proliferation of human dental pulp stem cell in vitro.
Wang X; He F; Tan Y; Tian W; Qiu S
Arch Oral Biol; 2011 Sep; 56(9):837-45. PubMed ID: 21392732
[TBL] [Abstract][Full Text] [Related]
30. Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions.
Denning-Kendall P; Singha S; Bradley B; Hows J
Stem Cells; 2003; 21(1):61-70. PubMed ID: 12529552
[TBL] [Abstract][Full Text] [Related]
31. Correlation between IL-3 receptor expression and growth potential of human CD34+ hematopoietic cells from different tissues.
Huang S; Chen Z; Yu JF; Young D; Bashey A; Ho AD; Law P
Stem Cells; 1999; 17(5):265-72. PubMed ID: 10527461
[TBL] [Abstract][Full Text] [Related]
32. [The investigation of ex-vivo expansion of hematopoietic stem/progenitor cells].
Fan X; Bao C; Liu Y; Liu T; Sun X; Ge D; Ma X
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):870-5. PubMed ID: 17899763
[TBL] [Abstract][Full Text] [Related]
33. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo.
Neildez-Nguyen TM; Wajcman H; Marden MC; Bensidhoum M; Moncollin V; Giarratana MC; Kobari L; Thierry D; Douay L
Nat Biotechnol; 2002 May; 20(5):467-72. PubMed ID: 11981559
[TBL] [Abstract][Full Text] [Related]
34. Systematic delineation of optimal cytokine concentrations to expand hematopoietic stem/progenitor cells in co-culture with mesenchymal stem cells.
Andrade PZ; dos Santos F; Almeida-Porada G; da Silva CL; S Cabral JM
Mol Biosyst; 2010 Jul; 6(7):1207-15. PubMed ID: 20424784
[TBL] [Abstract][Full Text] [Related]
35. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
[TBL] [Abstract][Full Text] [Related]
36. Ultrastructural and phenotypic analysis of in vitro erythropoiesis from human cord blood CD34+ cells.
Kie JH; Jung YJ; Woo SY; Ryu KH; Park HY; Chung WS; Seoh JY
Ann Hematol; 2003 May; 82(5):278-83. PubMed ID: 12679887
[TBL] [Abstract][Full Text] [Related]
37. Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells.
Delaney C; Varnum-Finney B; Aoyama K; Brashem-Stein C; Bernstein ID
Blood; 2005 Oct; 106(8):2693-9. PubMed ID: 15976178
[TBL] [Abstract][Full Text] [Related]
38. Measuring dissolved oxygen to track erythroid differentiation of hematopoietic progenitor cells in culture.
Browne SM; Daud H; Murphy WG; Al-Rubeai M
J Biotechnol; 2014 Oct; 187():135-8. PubMed ID: 25107508
[TBL] [Abstract][Full Text] [Related]
39. Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1.
Dallas MH; Varnum-Finney B; Martin PJ; Bernstein ID
Blood; 2007 Apr; 109(8):3579-87. PubMed ID: 17213287
[TBL] [Abstract][Full Text] [Related]
40. NOTCH-mediated ex vivo expansion of human hematopoietic stem and progenitor cells by culture under hypoxia.
Araki D; Fu JF; Huntsman H; Cordes S; Seifuddin F; Alvarado LJ; Cheruku PS; Cash A; Traba J; Li Y; Pirooznia M; Smith RH; Larochelle A
Stem Cell Reports; 2021 Sep; 16(9):2336-2350. PubMed ID: 34450041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
